1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA IL36A CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA HNRNPH1 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA NTN5 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA GFM2 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA FAM120B CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA NAMPT CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA TTC9B CTRPv2 pan-cancer AAC 0.15 0.0006
mRNA PRPF3 CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA TP53BP2 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA SPAST CTRPv2 pan-cancer AAC 0.11 0.0006
Download CSV